Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Veracyte (VCYT) over the last 6 years, with Dec 2024 value amounting to $78.2 million.

  • Veracyte's Shares Outstanding (Diluted Average) rose 1.89% to $79.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.9 million, marking a year-over-year increase of 1.89%. This contributed to the annual value of $78.2 million for FY2024, which is 7.60% up from last year.
  • As of FY2024, Veracyte's Shares Outstanding (Diluted Average) stood at $78.2 million, which was up 7.60% from $72.6 million recorded in FY2023.
  • Over the past 5 years, Veracyte's Shares Outstanding (Diluted Average) peaked at $78.2 million during FY2024, and registered a low of $53.2 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $72.6 million (2023), whereas its average is $74.1 million.
  • Data for Veracyte's Shares Outstanding (Diluted Average) shows a peak YoY grew of 27.52% (in 2021) over the last 5 years.
  • Over the past 5 years, Veracyte's Shares Outstanding (Diluted Average) (Yearly) stood at $53.2 million in 2020, then rose by 27.52% to $67.9 million in 2021, then increased by 5.39% to $71.5 million in 2022, then rose by 1.53% to $72.6 million in 2023, then climbed by 7.60% to $78.2 million in 2024.